MyFinsight
Home
Blog
About
Net loss and
comprehensive loss
-$3,782K
(48.57%↑ Y/Y)
Therapeutics
$5,112K
Diagnostics
$1,175K
Development Services
$362K
Therapeutics
$1,626K
Diagnostics
$210K
Development Services
$3K
Revenue From Contract
With Customer...
$979K
Development Services
$29K
Therapeutics
$16K
Net loss
-$3,765K
(49.11%↑ Y/Y)
Change in foreign
currency translation
-$12K
(-121.82%↓ Y/Y)
Unrealized loss, change in
fair value of...
-$5K
(50.00%↑ Y/Y)
Consumables Revenue
$6,649K
Capital Revenue
$1,839K
Engineering Revenue
$979K
Product And Service
Other
$45K
Loss before income
taxes
-$3,739K
(49.38%↑ Y/Y)
Income tax expense
(benefit)
$26K
(116.67%↑ Y/Y)
Interest income
$404K
(-35.77%↓ Y/Y)
Net revenue
$9,512K
(36.59%↑ Y/Y)
Loss from operations
-$4,083K
(49.18%↑ Y/Y)
Gross profit
$6,041K
(29.47%↑ Y/Y)
Other expense
-$43K
(-10.26%↓ Y/Y)
Foreign exchange (loss)
income
-$15K
(-125.86%↓ Y/Y)
Loss on disposal of
assets
-$2K
(-300.00%↓ Y/Y)
Cost of revenue
$3,471K
(51.04%↑ Y/Y)
General and
administrative
$5,379K
(-12.71%↓ Y/Y)
Selling and marketing
$3,675K
(-21.02%↓ Y/Y)
Research and development
$1,070K
(-43.27%↓ Y/Y)
Back
Back
Income Statement
Zomedica Corp. (ZOMDF)
Zomedica Corp. (ZOMDF)
source: myfinsight.com